UW–Madison School of Medicine and Public Health: Intends to be the first in the United States to install innovative cancer treatment
Home » Press Releases » UW–Madison School of Medicine and Public Health: Intends to be the first in the United States to install innovative cancer treatment
MADISON, Wis. – The University of Wisconsin–Madison and TAE Life Sciences, a biotechnology company specializing in targeted radiation therapy for cancer care, have signed a memorandum of understanding, or MOU, announcing the intention to launch the first accelerator-based boron neutron capture therapy center in the United States.
As part of this collaboration, the University of Wisc...
Please log in to access subscriber content.
If you don't have a subscription, please contact schmies@wispolitics.com for subscription options on the WisPolitics-State Affairs platform, which is the new home for WisPolitics subscriber products.
